[Cotrimoxazole for toxoplasmosis encephalitis: a cheaper and safer treatment?].
Béraud
G
G
Pierre-François
S
S
Foltzer
A
A
Smadja
D
D
Cabié
A
A
D000890:Anti-Infective Agents / Q000191:economics / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D003365:Costs and Cost Analysis; D004660:Encephalitis / Q000188:drug therapy / Q000382:microbiology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D012449:Safety; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000191:economics / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination